Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soffer

Showing results (961-970 of 1,518) with videos related to

Pageof 152
Sort By:
Immunity|September 5, 1998
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatallyE E Varfolomeev, M Schuchmann, V Luria, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) StudyFrancesco Franchi, Fabiana Rollini, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic DiseaseMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Journal of the American College of Cardiology|January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisSotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathwayZohar Tiran, Anat Oren, Chen Hermesh, et al.
JACC. Basic to Translational Science|August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CADLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Journal of Neural Engineering|December 9, 2017
Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performanceJohn K Hermann, Madhumitha Ravikumar, Andrew J Shoffstall, et al.
Journal of Clinical Lipidology|April 2, 2024
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practiceMarlys L Koschinsky, Archna Bajaj, Michael B Boffa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic SubjectsTiffany Thomas, Haihong Zhou, Wahida Karmally, et al.
JCI Insight|August 18, 2022
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progressionSabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, et al.
Pageof 152

Showing results (961-970 of 1,518) with videos related to

Sort By:
Pageof 152
Immunity|September 5, 1998
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatallyE E Varfolomeev, M Schuchmann, V Luria, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) StudyFrancesco Franchi, Fabiana Rollini, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic DiseaseMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Journal of the American College of Cardiology|January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisSotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathwayZohar Tiran, Anat Oren, Chen Hermesh, et al.
JACC. Basic to Translational Science|August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CADLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Journal of Neural Engineering|December 9, 2017
Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performanceJohn K Hermann, Madhumitha Ravikumar, Andrew J Shoffstall, et al.
Journal of Clinical Lipidology|April 2, 2024
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practiceMarlys L Koschinsky, Archna Bajaj, Michael B Boffa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic SubjectsTiffany Thomas, Haihong Zhou, Wahida Karmally, et al.
JCI Insight|August 18, 2022
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progressionSabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, et al.
Pageof 152